Radiofrequency ablation using a 10-mm target margin for small hepatocellular carcinoma in patients with liver cirrhosis: A prospective randomized trial

Author:

Liao Mingheng1,Zhong Xiaofei2,Zhang Jingyi2,Liu Yangyang3,Zhu Zexin1,Wu Hong1,Zeng Yong1,Huang Jiwei1ORCID

Affiliation:

1. Department of Liver Surgery; Liver Transplantation Division; West China Hospital; Sichuan University; Chengdu China

2. Department of Ultrasound; West China Hospital; Sichuan University; Chengdu China

3. Department of Radiology; West China Hospital; Sichuan University; Chengdu China

Funder

Key Technology Program of the Science and Technology Bureau of Sichuan Province, China

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference40 articles.

1. Current strategy for staging and treatment: the BCLC update and future prospects;Forner;Semin Liver Dis,2010

2. Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver transplantation;Huang;J Surg Res,2016

3. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment;Yang;World J Gastroenterol,2016

4. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors;Kim;J Hepatol,2013

5. Local recurrence and complications after percutaneous radiofrequency ablation of hepatocellular carcinoma: a retrospective cohort study focused on tumor location;Toshimori;Acta Med Okayama,2015

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3